Unicycive Therapeutics (UNCY) Accumulated Depreciation & Amortization (2021 - 2026)
Unicycive Therapeutics posted quarterly Accumulated Depreciation & Amortization of $58000.0 for Q1 2026, up 23.4% year-on-year from $47000.0 in Q1 2025, and down 19.44% on a QoQ basis from $72000.0 in Q4 2025.
Unicycive Therapeutics (UNCY) has 6 years of Accumulated Depreciation & Amortization data on file, last reported at $58000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization rose 23.4% year-over-year to $58000.0; the trailing twelve-month figure through Mar 2026 stood at $58000.0 (up 23.4% YoY), and the FY2025 full-year result was $72000.0, up 84.62% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $58000.0, down from $72000.0 in the prior quarter.
- Across five years, Accumulated Depreciation & Amortization topped out at $428000.0 in Q4 2022 and bottomed at $3000.0 in Q1 2022.
- The 5-year median for Accumulated Depreciation & Amortization is $25000.0 (2024), against an average of $52823.5.
- Peak annual rise in Accumulated Depreciation & Amortization reached 200.0% in 2023, while the deepest fall reached 96.26% in 2023.
- A 5-year view of Accumulated Depreciation & Amortization shows it stood at $428000.0 in 2022, then tumbled by 96.26% to $16000.0 in 2023, then surged by 143.75% to $39000.0 in 2024, then jumped by 84.62% to $72000.0 in 2025, then decreased by 19.44% to $58000.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $58000.0 (Q1 2026), $72000.0 (Q4 2025), and $63000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Unicycive Therapeutics | 181.94 Mn | 127.36 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 58,000.00 |
| Mar 31, 2026 | 58,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Dec 31, 2025 | 72,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Sep 30, 2025 | 63,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Jun 30, 2025 | 53,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Mar 31, 2025 | 47,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Dec 31, 2024 | 39,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Sep 30, 2024 | 31,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Jun 30, 2024 | 25,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Mar 31, 2024 | 19,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Dec 31, 2023 | 16,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Sep 30, 2023 | 14,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Jun 30, 2023 | 12,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Mar 31, 2023 | 8,000.00 |
| Dec 31, 2022 | 428,000.00 |
| Dec 31, 2022 | 428,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Sep 30, 2022 | 6,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Mar 31, 2022 | 3,000.00 |
| Dec 31, 2021 | 468,000.00 |
| Dec 31, 2021 | 468,000.00 |